Production (Stage)
Cellectis S.A.
CMVLF
$1.25
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -16.21% | -21.51% | |||
| Total Other Revenue | -43.94% | 32.31% | |||
| Total Revenue | -20.69% | -15.99% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -20.69% | -15.99% | |||
| SG&A Expenses | -4.66% | -4.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -1,006.38% | 126.86% | |||
| Total Operating Expenses | 1.40% | -10.33% | |||
| Operating Income | -32.77% | 0.84% | |||
| Income Before Tax | -381.67% | 127.84% | |||
| Income Tax Expenses | -- | 971.19% | |||
| Earnings from Continuing Operations | -406.11% | 125.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -406.11% | 125.69% | |||
| EBIT | -32.77% | 0.84% | |||
| EBITDA | -49.36% | 6.85% | |||
| EPS Basic | -405.74% | 125.71% | |||
| Normalized Basic EPS | -448.00% | 126.97% | |||
| EPS Diluted | -419.22% | 124.62% | |||
| Normalized Diluted EPS | -448.00% | 126.97% | |||
| Average Basic Shares Outstanding | 0.06% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||